← Leaderboards
Raffi V Aroian
Univ Of Massachusetts Med Sch Worcester
$19,935,756
Attributed
$20,148,881
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,148,881 · 9
By mechanism
R01$18,369,711 · 5
R21$1,779,170 · 4
Top collaborators
- William Fenical2 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Elyssa Campbell$99,958
- Rachel Fath Daniels$226,706
Others in their field
Top investigators on “Nematoda”
- Robert H Waterston · Washington University$37,465,600
- Paul Warren Sternberg · California Institute Of Technology$34,689,675
- Gordon J. Lithgow · Buck Institute For Age Research$23,578,719
- Albertha Johanna Walhout · Univ Of Massachusetts Med Sch Worcester$20,063,687
- Shai Shaham · Rockefeller University$19,313,693
- Daniel Edward Lee Promislow · University Of Georgia (Uga)$18,636,312
Research focus
NematodaProteinsAnimalsPharmaceutical PreparationsParasitesCaenorhabditis ElegansHookwormsIn VivoBacteriaIntestinesFutureAnthelminticsAdultResistanceInfectionLeadGrowthAncylostoma (Genus)ChildDoseProductivityMalnutritionSoilHamsters
Grant awards (52)
Combining B. thuringiensis crystal proteins with small molecule anthelmintics to combat parasitic nematode resistance$769,201
R01 · FY2025 · AI · contact PI
B. thuringiensis crystal proteins as powerful next-generation anthelmintics$715,337
R01 · FY2025 · AI · contact PI
B. thuringiensis crystal proteins as powerful next-generation anthelmintics$719,185
R01 · FY2024 · AI · contact PI
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs$203,087
R01 · FY2024 · AI · contact PI
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs$636,142
R01 · FY2023 · AI · contact PI
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans$450,660
R01 · FY2023 · HD · contact PI
B. thuringiensis crystal proteins as powerful next-generation anthelmintics$652,243
R01 · FY2022 · AI · contact PI
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans$450,660
R01 · FY2022 · HD · contact PI
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs$374,430
R01 · FY2022 · AI · contact PI
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs$658,387
R01 · FY2021 · AI · contact PI
B. thuringiensis crystal proteins as powerful next-generation anthelmintics$652,243
R01 · FY2021 · AI · contact PI
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans$450,660
R01 · FY2021 · HD · contact PI
Tapping into an anthelmintic Bacillus thuringiensis crystal protein arsenal for human strongyloidiasis$206,350
R21 · FY2021 · AI · contact PI
B. thuringiensis crystal proteins as powerful next-generation anthelmintics$664,967
R01 · FY2020 · AI · contact PI
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs$602,642
R01 · FY2020 · AI · contact PI
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans$509,703
R01 · FY2020 · HD · contact PI
Tapping into an anthelmintic Bacillus thuringiensis crystal protein arsenal for human strongyloidiasis$265,100
R21 · FY2020 · AI · contact PI
B. thuringiensis crystal proteins as powerful next-generation anthelmintics$653,009
R01 · FY2019 · AI · contact PI
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans$526,951
R01 · FY2019 · HD · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$624,809
R01 · FY2018 · AI · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$547,283
R01 · FY2017 · AI · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$593,268
R01 · FY2016 · AI · contact PI
Harnessing Transcriptomics to Identify and Test Novel Hookworm Vaccine Targets$243,572
R21 · FY2016 · AI · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$573,621
R01 · FY2015 · AI · contact PI
Harnessing Transcriptomics to Identify and Test Novel Hookworm Vaccine Targets$218,874
R21 · FY2015 · AI · contact PI
Mining marine microbial natural products for anthelmintics leads$193,750
R21 · FY2015 · AI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$430,096
R01 · FY2014 · AI · contact PI
MAPK-mediated defense pathways against pore-forming toxins$307,151
R01 · FY2014 · GM · contact PI
Mining marine microbial natural products for anthelmintics leads$232,500
R21 · FY2014 · AI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$123,136
R01 · FY2014 · AI · contact PI
MAPK-mediated defense pathways against pore-forming toxins$16,554
R01 · FY2014 · GM · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$386,949
R01 · FY2013 · AI · contact PI
MAPK-mediated defense pathways against pore-forming toxins$276,476
R01 · FY2013 · GM · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$411,649
R01 · FY2012 · AI · contact PI
MAPK-mediated defense pathways against pore-forming toxins$287,139
R01 · FY2012 · GM · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$411,817
R01 · FY2011 · AI · contact PI
MAPK-mediated defense pathways against pore-forming toxins$300,828
R01 · FY2011 · GM · contact PI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics$443,210
R01 · FY2010 · AI · contact PI
p38-mediated defense pathway against pore-forming toxins$98,478
R01 · FY2010 · GM · contact PI
Function/optimization of a nematicidal Cry toxin arsenal$325,402
R01 · FY2009 · AI · contact PI
p38-mediated defense pathway against pore-forming toxins$264,612
R01 · FY2009 · GM · contact PI
p38-mediated defense pathway against pore-forming toxins$93,577
R01 · FY2009 · GM · contact PI
Function/optimization of a nematicidal Cry toxin arsenal$326,389
R01 · FY2008 · AI · contact PI
p38-mediated defense pathway against pore-forming toxins$264,612
R01 · FY2008 · GM · contact PI
p38-mediated defense pathway against pore-forming toxins$17,304
R01 · FY2008 · GM · contact PI
Function/optimization of a nematicidal Cry toxin arsenal$355,687
R01 · FY2007 · AI · contact PI
p38-mediated defense pathway against pore-forming toxins$264,612
R01 · FY2007 · GM · contact PI
C. elegans model of B. anthracis immunity & pathogenesis$187,524
R21 · FY2007 · AI · contact PI
Function/optimization of a nematicidal Cry toxin arsenal$344,220
R01 · FY2006 · AI · contact PI
p38-mediated defense pathway against pore-forming toxins$282,881
R01 · FY2006 · GM · contact PI
C. elegans model of B. anthracis immunity & pathogenesis$231,500
R21 · FY2006 · AI · contact PI
Function/optimization of a nematicidal Cry toxin arsenal$308,444
R01 · FY2005 · AI